Causes of ischemic stroke in patients with non-valvular atrial fibrillation

Cerebrovascular Diseases

Volumn 42, Issue 3-4, 2016, Pages 196-204

  Nakamura, Asako ^a,b   Kuroda, Junya ^b   Ago, Tetsuro ^b   Hata, Jun ^b   Matsuo, Ryu ^b   Arakawa, Shuji ^c   Kuwashiro, Takahiro ^a   Yasaka, Masahiro ^a   Okada, Yasushi ^a   Kitazono, Takanari ^b   Kamouchi, Masahiro ^b  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU ROSAI HOSPITAL   (Japan)

Author keywords

Anticoagulants; Atrial fibrillation; Brain infarction

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CHADS2 SCORE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; NON VALVULAR ATRIAL FIBRILLATION; PRIORITY JOURNAL; PROTHROMBIN TIME; REGISTER; RETROSPECTIVE STUDY; SEX; SMOKING; BLOOD; BLOOD CLOTTING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFECTS; JAPAN; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD COAGULATION; BRAIN ISCHEMIA; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; JAPAN; MALE; PREVALENCE; PROTHROMBIN TIME; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; STROKE; TREATMENT OUTCOME; WARFARIN;

EID: 84973866191     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000445723     Document Type: Article

References (17)

1. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC Jr, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, de Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A; American College of Cardiology/American Heart Association/European Society of Cardiology Board: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Developed in Collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001; 104: 2118-2150.
2. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64:e1-e76.
3. Verheugt FW, Granger CB: Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs. Lancet 2015; 386: 303-310.
4. Kamouchi M, Matsuki T, Hata J, Kuwashiro T, Ago T, Sambongi Y, Fukushima Y, Sugimori H, Kitazono T; FSR Investigators: Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka stroke registry. Stroke 2011; 42: 2788-2794.
5. Kumai Y, Kamouchi M, Hata J, Ago T, Kitayama J, Nakane H, Sugimori H, Kitazono T; FSR Investigators: Proteinuria and clinical outcomes after ischemic stroke. Neurology 2012; 78: 1909-1915.
6. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. JAMA 2001; 285: 2864-2870.
7. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factorbased approach: the Euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272.
8. JCS Joint Working Group: Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013). Circ J 2014; 78: 1997-2021.
9. Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E: Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 2000; 10: 39-43.
10. Evans A, Perez I, Yu G, Kalra L: Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation? Stroke 2001; 32: 2828-2832.
11. Indredavik B, Rohweder G, Lydersen S: Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation. J Intern Med 2005; 258: 133-144.
12. Gladstone DJ, Bui E, Fang J, Laupacis A, Lindsay MP, Tu JV, Silver FL, Kapral MK: Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 2009; 40: 235-240.
13. Rose AJ, Ozonoff A, Grant RW, Henault LE, Hylek EM: Epidemiology of subtherapeutic anticoagulation in the United States. Circ Cardiovasc Qual Outcomes 2009; 2: 591-597.
14. Albertsen IE, Rasmussen LH, Overvad TF, Graungaard T, Larsen TB, Lip GY: Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis. Stroke 2013; 44: 1329-1336.
15. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P; Warfarin-Aspirin Recurrent Stroke Study Group: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345: 1444-1451.
16. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352: 1305-1316.
17. Evans A, Perez I, Yu G, Kalra L: Secondary stroke prevention in atrial fibrillation: lessons from clinical practice. Stroke 2000; 31: 2106-2111.